Shanghai Pharma seeks $655m for Cardinal Health acquisition refi

Pharmaceutical 230x150
By Pan Yue
02 Nov 2018

Shanghai Pharmaceutical Holding is raising a $655m dual-tranche facility to refinance a bridge loan that was used to support the acquisition of Cardinal Health (L).

ANZ, DBS, MUFG Bank and Natixis are the mandated lead arrangers and bookrunners, according to a banker who has received the invitation.  

The deal is split into two tranches, each with a different borrower. Shanghai Pharma is the borrower of tranche A, which has a size of ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial